GMP Manufacturing 

Axolabs is currently establishing a new site in Berlin for GMP manufacturing of Nucleic Acid Therapeutics (NAT).

The site will be dedicated to medium to large scale and early to late phase clinical GMP manufacturing of NAT. The state-of-the-art facility will deliver integrated analytical and manufacturing solutions. The operational start date is scheduled for 2024.